Report
EUR 14.02 For Business Accounts Only

ALLSCRIPTS HEALTH sees a downgrade to Slightly Negative on account of less fundamental stars

The independent financial analyst theScreener just lowered the general evaluation of ALLSCRIPTS HEALTH (US), active in the Software industry. As regards its fundamental valuation, the title now shows 1 out of 4 stars while market behaviour can be considered moderately risky. theScreener believes that the title remains under pressure due to the loss of a star(s) and downgrades its general evaluation to Slightly Negative. As of the analysis date January 18, 2022, the closing price was USD 17.52 and its target price was estimated at USD 15.10.
Underlying
Allscripts Healthcare Solutions Inc.

Allscripts Healthcare Solutions delivers information technology solutions and services. The company is engaged in providing electronic health records (EHRs), financial management, population health management, medicine and consumer solutions. The company's segments are: Clinical and Financial Solutions, which consists of the sale of integrated clinical software applications and financial and information solutions, including EHR-related software, connectivity and coordinated care solutions, financial and practice management software, related installation, and revenue cycle management; Population Health, which consists the sale of health management, financial management and patient engagement solutions.

Provider
TheScreener
TheScreener

Empowering Investors

theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals.  Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.

  • Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization.  theScreener state of art: We provide
  • theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
  • For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded

 

Other Reports on these Companies
Other Reports from TheScreener

ResearchPool Subscriptions

Get the most out of your insights

Get in touch